Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

The DDR1 receptor tyrosine kinase is activated by matrix collagens and has been implicated in numerous cellular functions such as proliferation, differentiation, adhesion, migration, and invasion. Here we report the discovery of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 Å...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Kim, H, Tan, L, Weisberg, E, Liu, F, Canning, P, Choi, H, Ezell, SA, Wu, H, Zhao, Z, Wang, J, Mandinova, A, Griffin, J, Bullock, A, Liu, Q, Lee, S, Gray, N
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2013

Những quyển sách tương tự

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
Bằng: Kim, H, et al.
Được phát hành: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors
Bằng: Canning, P, et al.
Được phát hành: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Bằng: Canning, P, et al.
Được phát hành: (2014)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
Bằng: Maria G. Nava, et al.
Được phát hành: (2023-02-01)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
Bằng: López-Ramos, M, et al.
Được phát hành: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
Bằng: López-Ramos, M, et al.
Được phát hành: (2010)

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
Bằng: William A. Denny, et al.
Được phát hành: (2021-11-01)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
Bằng: Panupong Mahalapbutr, et al.
Được phát hành: (2024-02-01)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
Bằng: Ronnakorn Leechaisit, et al.
Được phát hành: (2023-08-01)

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Bằng: Patrice Dubreuil, et al.
Được phát hành: (2009-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
Bằng: Xu H, et al.
Được phát hành: (2019-07-01)

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
Bằng: Sudarshan R Iyer, et al.
Được phát hành: (2023-10-01)

Recent Advances in Discovery of New Tyrosine Kinase Inhibitors Using Computational Methods
Bằng: Vesna Rastija
Được phát hành: (2019-08-01)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
Bằng: Chunmin Yang, et al.
Được phát hành: (2022-05-01)

Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.
Bằng: Hellwig, S, et al.
Được phát hành: (2012)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
Bằng: Lopez-Ramos, M, et al.
Được phát hành: (2011)

Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1
Bằng: C. Reger de Moura, et al.
Được phát hành: (2024-01-01)

Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells.
Bằng: Ellen Weisberg, et al.
Được phát hành: (2013-01-01)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
Bằng: Ian M. Catlett, et al.
Được phát hành: (2023-01-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
Bằng: Maria Dimou, et al.
Được phát hành: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
Bằng: Elisabetta Abruzzese, et al.
Được phát hành: (2014-04-01)

Second-generation inhibitors of Bruton tyrosine kinase
Bằng: Jingjing Wu, et al.
Được phát hành: (2016-09-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
Bằng: Cornelius Hempel, et al.
Được phát hành: (2017-01-01)

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
Bằng: Yangyang Yao, et al.
Được phát hành: (2017-10-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
Bằng: John J. Ryan, MD
Được phát hành: (2016-12-01)

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?
Bằng: Zhao, Z, et al.
Được phát hành: (2014)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
Bằng: Ainun Nizar Masbuchin, et al.
Được phát hành: (2022-09-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
Bằng: G. V. Lukina, et al.
Được phát hành: (2015-12-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
Bằng: Huang JT, et al.
Được phát hành: (2022-11-01)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
Bằng: Mark C Weir, et al.
Được phát hành: (2017-01-01)

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors
Bằng: Tatsuki Shibuta, et al.
Được phát hành: (2022-06-01)

Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
Bằng: Chris Liang, et al.
Được phát hành: (2022-03-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
Bằng: Jiangnan Liu, et al.
Được phát hành: (2024-03-01)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
Bằng: Wu J, et al.
Được phát hành: (2020-09-01)

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
Bằng: Muhammad Waleed Iqbal, et al.
Được phát hành: (2025-01-01)

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
Bằng: Pitsiou G, et al.
Được phát hành: (2014-10-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
Bằng: Matthew Walters, et al.
Được phát hành: (2020-11-01)

Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma
Bằng: Wei Dai, et al.
Được phát hành: (2021-05-01)

Tetrahydroisoquinoline-7-carboxamide derivatives as new selective discoidin domain receptor 1 (DDR1) inhibitors
Bằng: Bullock, A, et al.
Được phát hành: (2017)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
Bằng: Evan Pisick, et al.
Được phát hành: (2004-01-01)